Abstract
As in the fashion industry, trends in a particular area of scientific investigation often are fleeting but then return with renewed and enthusiastic interest. Studies of mast cell biology are good examples of this. Although dogma once relegated mast cells almost exclusively to roles in pathological inflammation associated with allergic disease, these cells are emerging as important players in a number of other physiological processes. Consequently, they are quickly becoming the newest “trendy” cell, both within and outside the field of immunology. As sources of a large array of pro- and anti-inflammatory mediators, mast cells also express cell surface molecules with defined functions in lymphocyte activation and trafficking. Here, we provide an overview of the traditional and newly appreciated contributions of mast cells to both innate and adaptive immune responses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Galli, S. J. and Lantz, C. S. (1999) Allergy, in Fundamental Immunology, 4th ed. (Paul, W. E., ed.), Lippincott-Raven Press, Philadelphia. pp. 1127–1174.
Taurog, J. D., Mendoza, G. R., Hook, W. A., Siraganian, R. P., and Metzger, H. (1977) Noncytotoxic IgE-mediated release of histamine and serotonin from murine mastocytoma cells. J. Immunol. 119, 1757–1761.
Barsumian, E. L., McGivney, A., Basciano, L. K., and Siraganian, R. P. (1985) Establishment of four mouse mastocytoma cell lines. Cell Immunol. 90, 131–141.
Siraganian, R. P. (2003) Mast cell signal transduction from the high-affinity IgE receptor. Curr. Opin. Immunol. 15, 639–646.
Pierce, J. H., Di Fiore, P. P., Aaronson, S. A., et al. (1985) Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41, 685–693.
Keller, G., Kennedy, M., Papayannopoulou, T., and Wiles, M. V. (1993) Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell Biol. 13, 473–486.
Ishizaka, T., Adachi, T., Chang, T. H., and Ishizaka, K. (1977) Development of mast cells in vitro. II. Biologic function of cultured mast cells. J. Immunol. 118, 211–217.
Valent, P., Sillaber, C., and Bettelheim, P. (1991) The growth and differentiation of mast cells. Prog. Growth Factor Res. 3, 27–41.
Denburg, J. A. (1990) Cytokine-induced human basophil/mast cell growth and differentiation in vitro. Springer Semin. Immunopathol. 12, 401–414.
Iemura, A., Tsai, M., Ando, A., Wershil, B. K., and Galli, S. J. (1994) The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am. J. Pathol. 144, 321–328.
Nakano, T., Sonoda, T., Hayashi, C., et al. (1985) Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/W v mice. J. Exp. Med. 162, 1025–1043.
Galli, S. J. and Kitamura, Y. (1987) Genetically mast-cell-deficient W/Wv and Sl/Sld mice: their value for the analysis of the roles of mast cells in biologic responses in vivo. Am. J. Pathol. 127, 191–198.
Galli, S. J., Tsai, M., Gordon, J. R., Geissler, E. N., and Wershil, B. K. (1992) Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci. Ann. N. Y. Acad. Sci. 664, 69–88.
Nocka, K., Tan, J. C., Chiu, E., et al. (1990) Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W 37, W v, W 41 and W. EMBO J. 9, 1805–1813.
Kitamura, Y., Go, S., and Hatanaka, K. (1978) Decrease of mast cells in W/W v mice and their increase by bone marrow transplantation. Blood 52, 447–452.
Duttlinger, R., Manova, K., Berrozpe, G., et al. (1995) The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Proc. Natl. Acad. Sci. USA 92, 3754–3758.
Yamazaki, M., Tsujimura, T., Morii, E., et al. (1994) C-kit gene is expressed by skin mast cells in embryos but not in puppies of Wsh/Wsh mice: age-dependent abolishment of c-kit gene expression. Blood 83, 3509–3516.
Duttlinger, R., Manova, K., Chu, T. Y., et al. (1993) W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118, 705–717.
Tono, T., Tsujimura, T., Koshimizu, U., et al. (1992) C-kit gene was not transcribed in cultured mast cells of mast cell-deficient Wsh/Wsh mice that have a normal number of erythrocytes and a normal c-kit coding region. Blood 80, 1448–1453.
Besmer, P., Manova, K., Duttlinger, R., et al. (1993) The kit-ligand (steel factor) and its receptor c-kit/W: pleiotropic roles in gametogenesis and melanogenesis. Dev. Suppl. 125–137.
Scharenber, A. M. and Kinet J. P. (1995) Early events in mast cell signal transduction, in Human Basophils and Mast Cells: Biological Aspects (Marone, G., ed.), Karger, Basel, pp. 72–87.
Okayama, Y., Tkaczyk, C., Metcalfe, D. D., and Gilfillan, A. M. (2003) Comparison of Fc epsilon RI-and Fc gamma RI-mediated degranulation and TNF-alpha synthesis in human mast cells: selective utilization of phosphatidylinositol-3-kinase for Fc gamma RI-induced degranulation. Eur J. Immunol. 33, 1450–1459.
Sylvestre, D. L. and Ravetch, J. V. (1996) A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity 5, 387–390.
Daeron, M., Malbec, O., Latour, S., Arock, M., and Fridman, W. H. (1995) Regulation of high-affinity IgE receptor-mediated mast cell activation by murine lowaffinity IgG receptors. J. Clin. Invest. 95, 577–585.
Marshall, J. S., McCurdy, J. D., and Olynych, T. (2003) Toll-like receptor-mediated activation of mast cells: implications for allergic disease? Int. Arch. Allergy Immunol. 132, 87–97.
el-Lati, S. G., Dahinden, C. A., Church, M. K., Dahinden, C. A., and Church, M. K. (1994) Complement peptides C3a-and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102, 803–806.
Fuereder, W., Agis, H., Willheim, M., et al. (1995) Differential expression of complement receptors on human basophils and mast cells. J. Immunol. 155, 3152–3160.
Wotja, J., Kaun, C., Zorn, G., et al. (2002) C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 100, 517–523.
Ansel, J. C., Brown, J. R., Payan, D. G., and Brown, M. A. (1993) Substance Pselectively activates TNF-alpha gene expression in murine mast cells. J. Immunol. 150, 4478–4485.
Galli, S. J. (1997) The mast cell: a versatile effector cell for a challenging world. Int. Arch. Allergy Immunol. 113, 14–22.
Kemp, S. F. and Lockey, R. F. (2002) Anaphylaxis: a review of causes and mechanisms. J. Allergy Clin. Immunol. 110, 341–348.
Galli, S. and Wershil, B. (1996) The two faces of the mast cell. Nature 381, 21–22.
Wills-Karp, M. and Hershey, G. K. K. (2003) Immunological mechanisms of allergic disorders, in Fundamental Immunology (Paul, W. E., ed.), Lippincott Williams and Wilkins, Philadelphia, pp. 1439–1479.
Gauchat, J. F., Henchoz, S., Mazzei, G., et al. (1993) Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340–343.
Jutel, M., Klunker, S., Akdis, M., et al. (2001) Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int. Arch. Allergy Immunol. 124, 190–192.
Jutel, M., Watanabe, T., Klunker, S., et al. (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420–425.
Mazzoni, A., Young, H. A., Spitzer, J. H., Visintin, A., and Segal, D. M. (2001) Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 108, 1865–1873.
Teuscher, C., Poynter, M. E., Offner, H., et al. (2004) Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells. Am. J. Pathol. 164, 883–892.
Montealegre, F., Quinones, C., Torres, N., and Goth, K. (2002) Detection of serine proteases in extracts of the domestic mite Blomia tropicalis. Exp. Appl. Acarol. 26, 87–100.
Miike, S. and Kita, H. (2003) Human eosinophils are activated by cysteine proteases and release inflammatory mediators. J. Allergy Clin. Immunol. 111, 704–713.
Bradding, P. (2003) The role of the mast cell in asthma: a reassessment. Curr. Opin. Allergy Clin. Immunol. 3, 45–50.
Marrack, P., Kappler, J., and Kotzin, B. L. (2001) Autoimmune disease: why and where it occurs. Nat. Med. 7, 899–905.
Martin, R., McFarland, H. F., and McFarlin, D. E. (1992) Immunological aspects of demyelinating diseases. Ann. Rev. Immunol. 10, 153–187.
Steinman, L. (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85, 299–302.
French-Constant, C. (1994) Pathogenesis of multiple sclerosis. Lancet 343, 271–275.
Kermode, A. G. (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 113, 1477–1489.
Neuman, J. (1890) Ueber das Vorkommen der sogneannten “Mastzellen” bei pathologischen Veraenderungen des Gehirns. Arch. Pathol. Anat. Physiol. Virchows 122, 378–381.
Bebo, B. F., Jr., Yong, T., Orr, E. L., and Linthicum, D. S. (1996) Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 45, 340–348.
Orr, E. L. (1988) Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis. Ann. N.Y. Acad. Sci. 540, 723–726.
Ibrahim, M. Z., Reder, A. T., Lawand, R., Takash, W., and Sallouh-Khatib, S. (1996) The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70, 131–138.
Brenner, T., Soffer, D., Shalit, M., and Levi-Schaffer, F. (1994) Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 122, 210–213.
Rozniecki, J. J., Hauser, S. L., Strein, M., Lincoln, R., and Theoharides, T. C. (1995) Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37, 63–66.
Dietsch, G. N. and Hinrichs, D. J. (1991) Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell. Immunol. 135, 541–548.
Johnson, D., Seeldrayers, P. A., and Weiner, H. L. (1988) The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 44, 195–198.
Johnson, D., Weiner, H. L., and Seeldrayers, P. A. (1988) Role of mast cells in peripheral nervous system demyelination. Ann. N.Y. Acad. Sci. 540, 727–731.
Johnson, D., Yasui, D., and Seeldrayers, P. (1991) An analysis of mast cell frequency in the rodent nervous system: Numbers vary between different strains and can be reconstituted in mast cell-deficient mice. J. Neuropath. Exp. Neurol. 50, 227–234.
Brosnan, C. F. and Tansey, F. A. (1984) Delayed onset of experimental allergic neuritis in rats treated with reserpine. J. Neuropathol. Exp. Neurol. 43, 84–93.
Dietsch, G. N. and Hinrichs, D. J. (1989) The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 142, 1476–1481.
Seeldrayers, P. A., Yasui, D., Weiner, H. L., and Johnson, D. (1989) Treatment of experimental allergic neuritis with nedocromil sodium, an anti-inflammatory drug with mast cell stabilizing properties. J. Neuroimmunol. 25, 221–226.
Pedotti, R., Mitchell, D., Wedemeyer, J., et al. (2001) An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2, 216–222.
Lock, C., Hermans, G., Pedotti, R., et al. (2002) Gene microarray analysis of multiple sclerosis lesions yield new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500–508.
Malfait, A. M., Malik, A. S., Marinova-Mutafchieva, L., Butler, D. M., Maini, R. N., and Feldmann, M. (1999) The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J. Immunol. 162, 6278–6283.
Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., and Brenner, M. B. (2002) Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689–1692.
Matsumoto, I., Lee, D. M., Goldbach-Mansky, R., et al. (2003) Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum. 48, 944–954.
Maccioni, M., Zeder-Lutz, G., Huang, H., et al. (2002) Arthritogenic monoclonal antibodies from K/BxN mice. J. Exp. Med. 195, 1071–1077.
Ji, H., Ohmura, K., Mahmood, U., et al. (2002) Arthritis critically dependent on innate immune system players. Immunity 16, 157–168.
Benoist, C. and Mathis, D. (2001) Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2, 797–801.
Matsumoto, I., Staub, A., Benoist, C., and Mathis, D. (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286, 1732–1735.
Ji, H., Korganow, A. S., Mangialaio, S., et al. (1999) Different modes of pathogenesis in T-cell-dependent autoimmunity: clues from two TCR transgenic systems. Immunol. Rev. 169, 139–146.
Wolley, D. E. and Tetlow, L. C. (2000) Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res. 2, 65–74.
Skopouli, F. N., Li, L., Boumba, D., et al. (1998) Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren’s syndrome. Clin. Exp. Rheumatol. 16, 63–65.
Baba, T., Sonozaki, H., Seki, K., Uchiyama, M., Ikesawa, Y., and Toriisu, M. (1976) An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients. J. Immunol. 116, 112–116.
Goldstein, S. M., Wasserman, S. I., and Wintroub, B. U. (1989) Mast cell and eosinophil mediated damage in bullous pemphigoid. Immunol. Ser. 46, 527–545.
Wintroub, B. U., Mihm, M. C., Jr., Goetzl, E. J., Soter, N. A., and Austen, K. F. (1978) Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N. Engl. J. Med. 298, 417–421.
Katayama, I., Doi, T., and Nishioka, K. (1984) High histamine level in the blister fluid of bullous pemphigoid. Arch. Dermatol. Res. 276, 126–127.
Ludgate, M. and Baker, G. (2002) Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin. Exp. Immunol. 127, 193–198.
Kiely, P. D., Pecht, I., and Oliveira, D. B. (1997) Mercuric chloride-induced vasculitis in the Brown Norway rat: alpha beta T cell-dependent and-independent phases: role of the mast cell. J. Immunol. 159, 5100–5106.
Esposito, I., Friess, H., Kappeler, A., et al. (2001) Mast cell distribution and activation in chronic pancreatitis. Hum. Pathol. 32, 1174–1183.
Esposito, I., Kleeff, J., Bischoff, S. C., et al. (2002) The stem cell factor-c-kit system and mast cells in human pancreatic cancer. Lab. Invest. 82, 1481–1492.
Dib, M., Zhao, X., Wang, X., and Andersson, R. (2002) Mast cells contribute to early pancreatitis-induced systemic endothelial barrier dysfunction. Pancreatology 2, 396–401.
Dib, M., Zhao, X., Wang, X. D., and Andersson, R. (2002) Role of mast cells in the development of pancreatitis-induced multiple organ dysfunction. Br. J. Surg. 89, 172–178.
Zimnoch, L., Szynaka, B., and Puchalski, Z. (2002) Mast cells and pancreatic stellate cells in chronic pancreatitis with differently intensified fibrosis. Hepatogastroenterology 49, 1135–1138.
Secor, V. H., Secor, W. E., Gutekunst, C. A., and Brown, M. A. (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191, 813–822.
Chen, R., Ning, G., Zhao, M. L., et al. (2001) Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108, 1151–1158.
Echtenacher, B., Mannel, D. N., and Hultner, L. (1996) Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75–77.
Malaviya, R., Ikeda, T., Ross, E., and Abraham, S. N. (1996) Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381, 77–80.
Garbuzenko, E., Nagler, A., Pickholtz, D., et al. (2002) Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis. Clin. Exp. Allergy 32, 237–246.
Hiromatsu, Y. and Toda, S. (2003) Mast cells and angiogenesis. Microsc. Res. Tech. 60, 64–69.
Gavrisheva, N. A. and Tkachenko, S. B. (2003) Mast cells in normal and diseased heart. Kardiologiia 43, 59–65.
Shiota, N., Rysa, J., Kovanen, P. T., Ruskoaho, H., Kokkonen, J. O., and Lindstedt, K. A. (2003) A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J. Hypertens. 21, 1935–1944.
Ren, G., Dewald, O., and Frangogiannis, N. G. (2003) Inflammatory mechanisms in myocardial infarction. Curr. Drug Targets Inflamm. Allergy 2, 242–256.
Iamaroon, A., Pongsiriwet, S., Jittidecharaks, S., Pattanaporn, K., Prapayasatok, S., and Wanachantararak, S. (2003) Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J. Oral Pathol. Med. 32, 195–199.
Samoszuk, M. and Corwin, M. A. (2003) Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer. Int. J. Cancer 107, 159–163.
Le Querrec, A., Duval, D., and Tobelem, G. (1993) Tumour angiogenesis. Baillieres Clin. Haematol. 6, 711–730.
Ranieri, G., Passantino, L., Patruno, R., et al. (2003) The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol. Rep. 10, 1189–1193.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Gregory, G.D., Brown, M.A. (2006). Mast Cells in Allergy and Autoimmunity. In: Krishnaswamy, G., Chi, D.S. (eds) Mast Cells. Methods in Molecular Biology, vol 315. Humana Press. https://doi.org/10.1385/1-59259-967-2:035
Download citation
DOI: https://doi.org/10.1385/1-59259-967-2:035
Publisher Name: Humana Press
Print ISBN: 978-1-58829-374-9
Online ISBN: 978-1-59259-967-7
eBook Packages: Springer Protocols